Clinical Factors and Composite Biomarkers Associated with Intensive Care Unit-Acquired Weakness: A Retrospective Cohort Study
- 1Department of Neurology, The Second Xiangya Hospital, Central South University, No. 139 Renmin Middle Road, Furong District, Changsha 410011, China
- 2Clinical Medical Research Center for Stroke Prevention and Treatment of Hunan Province, Department of Neurology, The Second Xiangya Hospital, Central South University, No. 139 Renmin Middle Road, Furong District, Changsha 410011, China
Abstract
Background/Objectives: Intensive care unit-acquired weakness is a common neuromuscular complication among critically ill patients, but associations of readily available composite biomarkers with this condition remain insufficiently characterized. This study aimed to investigate the clinical characteristics, risk factors, and composite biomarkers associated with intensive care unit-acquired weakness. Methods: This single-center retrospective cohort study included 135 critically ill patients admitted to intensive care units between December 2020 and December 2023. Patients were classified into an intensive care unit-acquired weakness group (n = 57) and a group without intensive care unit-acquired weakness (n = 78) according to Medical Research Council sum score criteria. Clinical characteristics, laboratory parameters, composite biomarkers, and hospitalization outcomes were compared. Multivariable logistic regression and receiver operating characteristic curve analyses were performed. Results: Older age, sepsis, hemodialysis, mechanical ventilation, and glucocorticoid use remained associated with intensive care unit-acquired weakness after adjustment for the other covariates in the model. Affected patients had lower albumin and hemoglobin levels and longer intensive care unit and hospital stays. The neutrophil-to-albumin ratio, inflammatory burden index, creatinine-to-albumin ratio, and serum urea-to-creatinine ratio were higher in affected patients. Receiver operating characteristic analysis showed modest discrimination, with areas under the curve ranging from 0.602 to 0.665. Conclusions: Intensive care unit-acquired weakness was associated with clinical and treatment-related factors, hypoalbuminemia, prolonged hospitalization, and elevated composite biomarkers. The composite biomarkers showed only modest discrimination, and their incremental values beyond clinical assessment and clinical utility remain unestablished. Residual confounding by illness severity and nutritional exposure cannot be excluded.
Related
- Identification of hepatitis B virus-associated membrane proteins as prognostic biomarkers for hepatocellular carcinoma based on retrospective analysis of integrated membrane proteomics
- Therapies for Alcohol Use Disorder in Alcohol-associated Hepatitis Clinical Trials: Integrated Trial Design with a Composite Clinical Outcome as the Primary Endpoint
- [Clinical characteristics and in-hospital outcomes of patients receiving antithrombotic therapy in a cardiac intensive care unit in sub-Saharan Africa: a retrospective comparative study at the Cardiology Institute of Abidjan].
- Digitally Guided Direct Composite Rehabilitation of a Maxillary Central Incisor Crown Fracture Associated With Multiple Diastemas: A 24-Month Clinical Case Report.
- Specialty-associated differences in intensive care unit rotation exit examination performance: a single-center retrospective cross-sectional study.
BibTeX
@article{zhang2026clinical,
title = {{Clinical Factors and Composite Biomarkers Associated with Intensive Care Unit-Acquired Weakness: A Retrospective Cohort Study}},
author = {Qiang Zhang and Jie Li and Yi Shu and Qihua Chen and Qiang Lei and Hainan Zhang and Jia Fang},
journal = {Journal of Clinical Medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15208171},
url = {https://www.mdpi.com/2077-0383/15/20/8171},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Clinical Factors and Composite Biomarkers Associated with Intensive Care Unit-Acquired Weakness: A Retrospective Cohort Study
AU - Qiang Zhang
AU - Jie Li
AU - Yi Shu
AU - Qihua Chen
AU - Qiang Lei
AU - Hainan Zhang
AU - Jia Fang
PY - 2026
DA - 2026/10/01
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15208171
UR - https://www.mdpi.com/2077-0383/15/20/8171
AB - Background/Objectives: Intensive care unit-acquired weakness is a common neuromuscular complication among critically ill patients, but associations of readily available composite biomarkers with this condition remain insufficiently characterized. This study aimed to investigate the clinical characteristics, risk factors, and composite biomarkers associated with intensive care unit-acquired weakness. Methods: This single-center retrospective cohort study included 135 critically ill patients admitted to intensive care units between December 2020 and December 2023. Patients were classified into an intensive care unit-acquired weakness group (n = 57) and a group without intensive care unit-acquired weakness (n = 78) according to Medical Research Council sum score criteria. Clinical characteristics, laboratory parameters, composite biomarkers, and hospitalization outcomes were compared. Multivariable logistic regression and receiver operating characteristic curve analyses were performed. Results: Older age, sepsis, hemodialysis, mechanical ventilation, and glucocorticoid use remained associated with intensive care unit-acquired weakness after adjustment for the other covariates in the model. Affected patients had lower albumin and hemoglobin levels and longer intensive care unit and hospital stays. The neutrophil-to-albumin ratio, inflammatory burden index, creatinine-to-albumin ratio, and serum urea-to-creatinine ratio were higher in affected patients. Receiver operating characteristic analysis showed modest discrimination, with areas under the curve ranging from 0.602 to 0.665. Conclusions: Intensive care unit-acquired weakness was associated with clinical and treatment-related factors, hypoalbuminemia, prolonged hospitalization, and elevated composite biomarkers. The composite biomarkers showed only modest discrimination, and their incremental values beyond clinical assessment and clinical utility remain unestablished. Residual confounding by illness severity and nutritional exposure cannot be excluded.
SN - 2077-0383
ER -